← Back to Search

Procedure

modified Health- Dx™ (mHDx) control capsule for Healthy Subjects

N/A

Recruiting

Research Sponsored by Celero Systems, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up day 1

Awards & highlights

Study Summary

This trial will test how well people can tolerate a new health capsule made by Celero Systems.

Who is the study for?

This trial is for healthy individuals between the ages of 18 and 75 who have agreed to participate and signed a consent form. They should not be at risk for gastrointestinal issues, have conditions affecting the GI tract, severe obesity (BMI > 40), or wireless medical devices. Pregnant or nursing subjects, those unable to swallow large capsules, or anyone planning an MRI within 30 days are excluded.Check my eligibility

What is being tested?

The study is testing two types of capsules: one is Celero Systems' modified Health-Dx™ capsule and the other a control version. Participants will randomly receive one type without knowing which they received (single-blind) to assess how well they tolerate it.See study design

What are the potential side effects?

While specific side effects aren't listed, tolerability generally refers to how easily participants can take the capsules without discomfort or adverse reactions such as digestive upset.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ day 1

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~day 1

This trial's timeline: 3 weeks for screening, Varies for treatment, and day 1 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

The difference, if any, in tolerability between the Study and Control as reported via the study questionnaire. mHDx as reported by the subjects.

Trial Design

2Treatment groups

Experimental Treatment

Group I: modified Health- Dx™ (mHDx) study capsuleExperimental Treatment1 Intervention

Group II: modified Health- Dx™ (mHDx) control capsuleExperimental Treatment1 Intervention

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Celero Systems, Inc.Lead Sponsor

1 Previous Clinical Trials

20 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals currently eligible to apply for participation in this ongoing medical study?

"Information available on clinicaltrials.gov indicates that this research endeavor is actively pursuing suitable candidates. The trial was initially listed on 26th July 2023 and underwent its most recent update on 26th January 2024."

Answered by AI

What is the current participation count in this clinical trial?

"Indeed, as per clinicaltrials.gov data, this research study is presently in the participant recruitment phase. It was initially listed on July 26th, 2023 and last revised on January 26th, 2024. The trial aims to enroll a total of 10 patients at a single site."

Answered by AI

What criteria must individuals meet to qualify for participation in this research study?

"To be eligible for enrollment, individuals must meet the criteria of being in good health and aged between 18 to 75 years. The study aims to recruit a cohort of 10 participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Tolerability of a Modified Health-Dx

2023. "Tolerability of a Modified Health-Dx". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06240650.

All > Paid Studies Pittsburgh